Sequential treatment patterns over time for advanced renal cell carcinoma: data from the German research platform CARAT. 3. August 2023 P J Goebell; C Grüllich; L Müller; M Bögemann; U Martens; E von der Heyde; D Reichert; A Nusch; A Schlenska-Lange; N Wetzel; M Koska; M Jänicke; N Marschner; M Staehler; V Grünwald, 2022. Oncol Res Treat 2022;45(suppl 1):796 Download The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice. Martens UM, Schröder J, Bengsch F, Sellmann L, Busies S, Frank-Gleich S, Zaiss M, Decker T, Schneeweiss A, Schuler M, Grebhardt S, Zacharias S, Marschner… Weiterlesen Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+ / HR+ early breast cancer (eBC). D Lüftner; R Bartsch; U Breitenstein; M Balic; C Jackisch; V Müller; G Rinnerthaler; M Schmidt; M Schwitter; K Zaman; D Wrobel; D Guth; J… Weiterlesen